| KRAB–zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading AC Groner, S Meylan, A Ciuffi, N Zangger, G Ambrosini, N Dénervaud, ... PLoS genetics 6 (3), e1000869, 2010 | 412 | 2010 |
| Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control S Meylan, CBM Porter, JH Yang, P Belenky, A Gutierrez, MA Lobritz, ... Cell chemical biology 24 (2), 195-206, 2017 | 302 | 2017 |
| Targeting antibiotic tolerance, pathogen by pathogen S Meylan, IW Andrews, JJ Collins Cell 172 (6), 1228-1238, 2018 | 168 | 2018 |
| Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on … S Cesaro, P Ljungman, M Mikulska, HH Hirsch, M von Lilienfeld-Toal, ... Leukemia 36 (6), 1467-1480, 2022 | 112 | 2022 |
| Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination S Meylan, F Livio, M Foerster, PJ Genoud, F Marguet, G Wuerzner, ... Hypertension 77 (6), e56-e57, 2021 | 88 | 2021 |
| Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control. Cell Chem Biol 24: 195–206 S Meylan, CBM Porter, JH Yang, P Belenky, A Gutierrez, MA Lobritz, ... | 49 | 2017 |
| When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus R Kuehl, L Morata, S Meylan, J Mensa, A Soriano Journal of Antimicrobial Chemotherapy 75 (5), 1071-1086, 2020 | 44 | 2020 |
| A gene-rich, transcriptionally active environment and the pre-deposition of repressive marks are predictive of susceptibility to KRAB/KAP1-mediated silencing S Meylan, AC Groner, G Ambrosini, N Malani, S Quenneville, N Zangger, ... BMC genomics 12, 1-14, 2011 | 33 | 2011 |
| Real-time PCR for type-specific identification of herpes simplex in clinical samples: evaluation of type-specific results in the context of CNS diseases S Meylan, D Robert, C Estrade, V Grimbuehler, O Péter, PR Meylan, ... Journal of clinical virology 41 (2), 87-91, 2008 | 25 | 2008 |
| ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol A Kotsaki, P Pickkers, M Bauer, T Calandra, M Lupse, WJ Wiersinga, ... BMJ open 12 (12), e067251, 2022 | 18 | 2022 |
| Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines P Ekobena, LE Rothuizen, F Bedussi, P Guilcher, S Meylan, A Ceschi, ... International Journal of Audiology 62 (6), 587-591, 2023 | 17 | 2023 |
| An Early Warning Score to predict ICU admission in COVID-19 positive patients S Meylan, R Akrour, J Regina, PA Bart, F Dami, T Calandra Journal of Infection 81 (5), 816-846, 2020 | 17 | 2020 |
| Dé nervaud, N., Bucher, P., and Trono, D.(2010). KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading AC Groner, S Meylan, A Ciuffi, N Zangger, G Ambrosini PLoS Genet 6, e1000869, 0 | 16 | |
| SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study S Meylan, U Dafni, F Lamoth, Z Tsourti, MA Lobritz, J Regina, P Bressin, ... BMJ open 11 (7), e049232, 2021 | 15 | 2021 |
| In the name of common sense: EUCAST breakpoints and potential pitfalls S Meylan, B Guery Clinical Microbiology and Infection 26 (12), 1593-1594, 2020 | 14 | 2020 |
| National Early Warning Score (NEWS) outperforms quick sepsis-related organ failure (qSOFA) score for early detection of sepsis in the emergency department D Durr, T Niemi, J Despraz, S Tusgul, F Dami, R Akrour, PN Carron, ... Antibiotics 11 (11), 1518, 2022 | 13 | 2022 |
| Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 … S Cesaro, M Mikulska, HH Hirsch, J Styczynski, S Meylan, C Cordonnier, ... Leukemia 37 (9), 1933-1938, 2023 | 12 | 2023 |
| Intradermal testing with COVID-19 mRNA vaccines predicts tolerance F Stehlin, R Mahdi-Aljedani, L Canton, V Monzambani-Banderet, ... Frontiers in allergy 3, 818049, 2022 | 10 | 2022 |
| Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections JJ Collins, S Meylan, S Moskowitz US Patent 11,382,883, 2022 | 5 | 2022 |
| Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period C Lazor-Blanchet, P Zygoura, U Dafni, F Lamoth, Z Tsourti, MA Lobritz, ... The Journal of Infection 84 (5), 722, 2022 | 4 | 2022 |
